The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 03, 2015

Filed:

Jun. 24, 2010
Applicants:

Paul Weinberger, Augusta, GA (US);

John M. Koomen, Tampa, FL (US);

Willam Shelley Dynan, Augusta, GA (US);

David James Terris, Martinez, GA (US);

Mark Asher Markley, Rochester, NY (US);

Inventors:

Paul Weinberger, Augusta, GA (US);

John M. Koomen, Tampa, FL (US);

Willam Shelley Dynan, Augusta, GA (US);

David James Terris, Martinez, GA (US);

Mark Asher Markley, Rochester, NY (US);

Assignee:

Other;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 49/00 (2006.01); A61K 38/18 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 9/51 (2006.01); A61K 47/20 (2006.01); A61K 47/42 (2006.01); A61K 38/17 (2006.01);
U.S. Cl.
CPC ...
A61K 38/18 (2013.01); A61K 9/0019 (2013.01); A61K 9/0092 (2013.01); A61K 9/06 (2013.01); A61K 9/5153 (2013.01); A61K 47/20 (2013.01); A61K 47/42 (2013.01); A61K 38/179 (2013.01);
Abstract

Described herein are sensitive methods for determining if a subject has cancer. The methods generally involve quantifying the amount of one or more biomarkers derived from Galectin-3 in a biological sample from the subject by mass spectrometry, wherein an increase in the amount of one or more biomarkers in the biological sample as compared to a control is an indication of the presence of cancer in the subject.


Find Patent Forward Citations

Loading…